Pulmonary imaging

Twigg HL (1998) Pulmonary host defenses. J Thorac Imaging 13 221-233. 

In the following section, all literature known predominantly 3-aryloxy-2-propa-nolamine-type p-AR radioligands are considered concerning their accessibility for F-radiolabeling. In addition, the radioligands are discussed from the radio-pharmacological point of view. The feasibility to specifically image pulmonary, cardiac as well as cerebral jS-ARs in vivo is also considered. 

The sample used for a demonstration of broadband TPF imaging with compressed PCF supercontinuum in Figure 7.17 was a commercially available test slide (Invitrogen FluoCells , prepard slide 1, containing labeled bovine pulmonary artery endothelial cells). The conventional optical phase-contrast microscopy image... 

Pulmonary and Cardiac Imaging, edited by C. Chiles and C. E. Putman... 

Kr81 13 s Pulmonary ventilation images in asthmatic patients, and for the early... 

Physical sensors (i) Thermal measurement (e.g. core body temperature, surface temperature mapping) (ii) mechanical measurement (e.g. non-invasive sphygmomanometer for blood pressure measurements, spirometer for determination of breathing and pulmonary function) (iii) acoustic measurement (e.g. ultrasound imaging, Doppler sonography for determination of blood flow) and (iv) radiation measurement (e.g. X-ray imaging, CT scanning). 

No routine imaging studies are indieated 0 Chest radiography is indicated to deteet acute respiratory distress syndrome (ARDS) in patients with pulmonary symptoms... 

It appears that imaging DVT was quite easily feasible in experimental and clinical trials. Whether imaging of pulmonary emboli in a clinical situation with monoclonal antifibrin antibody would be successful is not known. Experimentally, Kanke et al. showed that 64C5 monoclonal antifibrin was able to image PE. However, small PE of <50 mg were not visualized in vivo by gamma imaging despite a correlation between clot size and total antifibrin uptake. Further improvements are needed to make this method of detection of DVT or PE a clinical reality. 

Fig. 16 shows representative scintigraphic images from both the DPI and the EHD pulmonary drug delivery device. It can be seen that the EHD pulmonary drug delivery device produced a uniform deposition distribution through the lung field with only... 

Fleming, J.S. Halson, P. Conway, J. Moore, E. Nassim, M.A. Hashish, A.H. Bailey, A.G. Holgate, S.T. Martonen, T.B. Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodahty imaging. J. Nucl. Med. 1996, 37 (5), 873-877. 

Thurnheer R, Laube 1, Kaufmann PA, Stumpe KD, Stammberger U, Bloch KE, Weder W, Russi EW. Practicability and safety of dipyridamole cardiac imaging in patients with severe chronic obstructive pulmonary disease. Eur J Nucl Med 1999 26(8) 812-17. 

Day A. Lessons in women s health body image and pulmonary disease. CMAJ 1998 159(4) 346-9. 

The ideal contrast agent for enhancing ultrasound images and Doppler signals would be non-toxic, injectable intravenously, capable of crossing the pulmonary capillary bed, stable for the duration of the ultrasound examination, and useful for both Doppler and grey scale enhancement. 

---